Expanding Product Portfolio LivaNova boasts a diverse and advanced product portfolio in cardiovascular and neurostimulation technologies, presenting opportunities for cross-selling and expanding into hospitals currently using competing devices.

Global Market Presence With over 100 countries served and more than 5,000 hospitals worldwide, LivaNova's extensive international reach allows sales teams to target emerging markets and region-specific healthcare providers.

Growth in Revenue LivaNova reported a 14.3% year-over-year increase in revenue reaching approximately $362 million in the first quarter of 2026, indicating strong sales momentum and potential for further upselling.

Leadership Expansion Recent appointments of board and executive leaders, including new directors and a Chief Legal Officer, signal strategic growth initiatives and increased organizational stability, fostering investor and partner confidence.

Market Competition & Innovation LivaNova is positioned as a competitor in neurostimulation devices, rivaling established brands like Inspire Medical and Nyxoah, presenting opportunities to differentiate through new technologies and customized solutions.